CTOs on the Move

Aledade

www.aledade.com

 
Aledade is a new company with an old-fashioned goal: putting doctors back in control of health care. Aledade partners with independent, primary care physicians to provide everything the doctors need to create and run an Accountable Care Organization (ACO) – from business and practice transformation services to upfront capital and a cutting-edge technology platform. Our customized solutions – and our continuous, on-the-ground support of our physician partners – will help doctors in all types of communities across America preserve their autonomy, deliver better care to their patients, reduce overall costs, and keep independent physician practices flourishing.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.aledade.com
  • 4550 Montgomery Ave Suite 950
    Bethesda, MD USA 20814
  • Phone: 202.803.7979

Executives

Name Title Contact Details
Jonas Goldstein
Senior VP, Transformation Profile
Ritwik Tewari
Chief Technology Officer Profile
Tyson Kopczynski
Chief Information Security Officer Profile
Kallie Smith
Director Information Security Profile
Eric Banks
Chief Information Security Officer Profile

Funding

Aledade raised $30M on 06/15/2015
Aledade raised $20M on 01/11/2017
Aledade raised $23M on 12/19/2017
Aledade raised $46.1M on 10/17/2018
Aledade raised $10M on 01/19/2019
Aledade raised $64M on 04/20/2020
Aledade raised $100M on 01/19/2021
Aledade raised $123M on 06/06/2022

Similar Companies

DNA SOLUTIONS

DNA SOLUTIONS is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

northcoast medical

northcoast medical is a Morgan Hill, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novagen

Novagen is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Senda Biosciences

Senda Biosciences, Inc. is uniquely positioned to transform human health by harnessing millions of years of evolution to program targeted, potent and tunable medicines. Nature has provided the codes to program human cells – both within the cell (mRNA), and, remarkably, to the cell - using what surrounds it. The trillions of non-human cells in the human ecosystem have evolved natural nanoparticles that precisely shuttle biomolecules into human cells, providing the missing pieces to fully unlock programmable medicines. Senda`s proprietary platform includes the first-ever atlas of nature-derived programmable systems at the molecular level and across all kingdoms of life – accessing the entire code provided by nature required to program cells. With this platform, Senda is developing a new class of SendRNA™ medicines. The unique properties of these medicines create new frontiers for mRNA therapeutics and vaccines for infectious, genetic, autoimmune, and metabolic diseases and oncology indications – with further potential to transform the gene editing and protein-based therapy landscapes as well. Based in Cambridge, MA, Senda was founded by Flagship Pioneering.